Skip to Main Content

Author Details

Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
1989
804
93
PMIDPaper TitleJournal TitlePublished Year
37097462Letter to the Editors: "Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination" by C. Schwab et al.Clin Res Cardiol2024
37872280Integrated genotype-phenotype analysis of familial adenomatous polyposis-associated hepatocellular adenomas.Virchows Arch2024
36379463Profound tumor response to combined CTLA-4 and PD-1 inhibition in systemic fourth line therapy observed in a patient with hepatocellular carcinoma harboring SETD2 and LRP1B mutations.Z Gastroenterol2023
37864096Multicentric pilot study to standardize clinical whole exome sequencing (WES) for cancer patients.NPJ Precis Oncol2023
37562657Deep Learning-Enabled Diagnosis of Liver Adenocarcinoma.Gastroenterology2023
37916976Etiology-independent activation of the LTβ-LTβR-RELB axis drives aggressiveness and predicts poor prognosis in HCC.Hepatology2023
37661783Metallothionein: a game changer in histopathological diagnosis of Wilson disease.Histopathology2023
37792098[Regulation (EU) 2017/746 (IVDR): practical implementation of annex I in pathology].Pathologie (Heidelb)2023
37586177Analysis of rare fusions in NSCLC: Genomic architecture and clinical implications.Lung Cancer2023
37987816Wilko Weichert : 22.09.1970â¿¿10.07.2023.Pathologie (Heidelb)2023
38047950Regulation (EU) 2017/746 (IVDR): practical implementation of annex I in pathology.Pathologie (Heidelb)2023
37874352Standardized and quality-assured predictive PD-L1 testing in the upper gastrointestinal tract.J Cancer Res Clin Oncol2023
37352862An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targets.Cancer Cell2023
37059713Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis.Cell Death Discov2023
37058257DNA-Methylome-Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy.Clin Cancer Res2023
37455247Implementation of precision medicine in healthcare-A European perspective.J Intern Med2023
37381005α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration.Cell Commun Signal2023
37280276The German Network for Personalized Medicine to enhance patient care and translational research.Nat Med2023
37079858Durable Response With Sequential Tyrosine Kinase Inhibitor Treatment in a Patient With ROS1 Fusion-Positive Pancreatic Adenocarcinoma: A Case Report.JCO Precis Oncol2023
37145111Lethality of SARS-CoV-2 infection-a comparative autopsy study focusing on COVID-19 development and virus variants.Histopathology2023
37040776S3-Leitlinie Diagnostik und Therapie biliärer Karzinome ⿿ Langversion.Z Gastroenterol2023
37141769Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas.Lung Cancer2023
37327584Accurate tumor purity determination is critical for the analysis of homologous recombination deficiency (HRD).Transl Oncol2023
36788095High-Grade Endometrial Stromal Sarcomas With YWHAE::NUTM2 Gene Fusion Exhibit Recurrent CDKN2A Alterations and Absence of p16 Staining is a Poor Prognostic Marker.Mod Pathol2023
36852573Real-world data for precision cancer medicine-A European perspective.Genes Chromosomes Cancer2023
36436002Autopsy-based histopathological characterization of myocarditis after anti-SARS-CoV-2-vaccination.Clin Res Cardiol2023
36735063Structure and content of the EU-IVDR : Current status and implications for pathology.Pathologie (Heidelb)2023
36635225First proficiency testing for NGS-based and combined NGS- and FISH-based detection of FGFR2 fusions in intrahepatic cholangiocarcinoma.J Pathol Clin Res2023
36036272Hormone pathway comparison in non-idiopathic and idiopathic progressive subglottic stenosis.Eur Arch Otorhinolaryngol2023
33468537Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis.Gut2022
35384413Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types.J Pathol Clin Res2022
35804866N-Cadherin Distinguishes Intrahepatic Cholangiocarcinoma from Liver Metastases of Ductal Adenocarcinoma of the Pancreas.Cancers (Basel)2022
35841694Biobanking in times of crisis - The COVID-19 Autopsy and Biosample Registry Baden-Wuerttemberg.Pathol Res Pract2022
35797854Cell tropism and viral clearance during SARS-CoV-2 lung infection.Pathol Res Pract2022
35365377Corrigendum to "Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology 29 suppl. 4 (2018) v238-iv255].Ann Oncol2022
35394006Higher vitamin B6 status is associated with improved survival among patients with stage I-III colorectal cancer.Am J Clin Nutr2022
35364700Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?Virchows Arch2022
35815421Digital Staging of Hepatic Hemangiomas Reveals Spatial Heterogeneity in Endothelial Cell Composition and Vascular Senescence.J Histochem Cytochem2022
35658398Multicenter Evaluation of Tissue Classification by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging.Anal Chem2022
35681079Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD).NPJ Precis Oncol2022
36555099Lipid Droplet-Associated Proteins Perilipin 1 and 2: Molecular Markers of Steatosis and Microvesicular Steatotic Foci in Chronic Hepatitis C.Int J Mol Sci2022
36611868PNPLA3(I148M) Inhibits Lipolysis by Perilipin-5-Dependent Competition with ATGL.Cells2022
36001148Qualitätssicherung in der Pathologie.Pathologie (Heidelb)2022
35871236Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing.Br J Cancer2022
36068277Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesis.Br J Cancer2022
35867152Correction to: The impact of major extended donor criteria on graft failure and patient mortality after liver transplantation.Langenbecks Arch Surg2022
36099423Associations of Individual and Combined Physical Activity and Body Mass Index Groups with Proinflammatory Biomarkers among Colorectal Cancer Patients.Cancer Epidemiol Biomarkers Prev2022
35986087Precision oncology for intrahepatic cholangiocarcinoma in clinical practice.Br J Cancer2022
35925318[Erratum to: Genes and pathways: FGFR2 translocations and gene fusion analysis].Pathologie (Heidelb)2022
35925311[Genes and pathways: FGFR2 translocations and gene fusion analysis].Pathologie (Heidelb)2022
  • 1 - 50 of 804

Recommended Authors

Khashayar Asadi
Austin Hospital
Career Start Year 2015
Number of shared co-authors 1
Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 1
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 3
Johannes Haybaeck
Institute of Pathology, Medical University of Innsbruck
Career Start Year 2007
Number of shared co-authors 7
Reza Ghasemi
Washington University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Umesh Bhanot
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 3
Itzhak Avital
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 5
Ralf Kemmerling
Institute of Pathology, Paracelsus Medical University
Career Start Year 2000
Number of shared co-authors 1
Arief A Suriawinata
Dartmouth Hitchcock Medical Center
Career Start Year 1999
Number of shared co-authors 1
Christopher J Howlett
Western University
Career Start Year 1999
Number of shared co-authors 0
Patrizia Moser
Medical University of Innsbruck
Career Start Year 1999
Number of shared co-authors 1
Ni Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 1
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 5
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 1
Anirban Maitra
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 9
Tatsuhiro Shibata
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 2
Oliver F Bathe
Cumming School of Medicine, University of Calgary
Career Start Year 1991
Number of shared co-authors 9
Enzo Medico
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 5
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 3
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 15
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 1
Silvano Bosari
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 1
Christopher L Corless
Oregon Health & Science University
Career Start Year 1985
Number of shared co-authors 11
Cuong Hoang-Vu
Center for Cancer Research, National Cancer Institute
Career Start Year 1985
Number of shared co-authors 2
Francisco X Real
Spanish National Cancer Research Centre-CNIO
Career Start Year 1983
Number of shared co-authors 1
Hoguen Kim
Korea Advanced Institute of Science and Technology (KAIST)
Career Start Year 1982
Number of shared co-authors 1
David M Berman
Queen's University
Career Start Year 1982
Number of shared co-authors 2
Maria J Merino
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 6
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 0
Ming-Sound Tsao
University Health Network, University of Toronto
Career Start Year 1972
Number of shared co-authors 10

Collaborators

Albrecht Stenzinger
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 126
Thomas Longerich
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 90
Esther Herpel
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 68
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 66
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 52
Anna-Lena Volckmar
Institut fur Pathologie, Universitatsklinikum Heidelberg
Co-authored papers 43
Martina Kirchner
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 43
Stephanie Roessler
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 42
Daniel Kazdal
Institut fur Pathologie, Universitatsklinikum Heidelberg
Co-authored papers 39
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Co-authored papers 37
Olaf Neumann
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 35
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Co-authored papers 32
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Co-authored papers 23
Benedikt Brors
German Cancer Research Center (DKFZ)
Co-authored papers 17
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Co-authored papers 17
Arndt Vogel
Clinic for Gastroenterology, Medical University Hannover
Co-authored papers 15
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Co-authored papers 12
Christoph Plass
German Cancer Research Center
Co-authored papers 12
Andreas von Deimling
Co-authored papers 12
Thomas Albrecht
Institute of Pathology, Heidelberg University Hospital
Co-authored papers 12
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Co-authored papers 11
Lars Zender
Co-authored papers 10
Roland Eils
Berlin Institute of Health (BIH) and Charite
Co-authored papers 10
Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Co-authored papers 9
Holger S??ltmann
German Cancer Research Center (DKFZ)
Co-authored papers 9
David Capper
Charite University Medicine Berlin
Co-authored papers 8
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers 8
Ivo Buchhalter
German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK)
Co-authored papers 8
Alessandro Ori
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)
Co-authored papers 7
Dieter Weichenhan
German Cancer Research Center (DKFZ)
Co-authored papers 7
Release 1.2